徐放性医薬製剤 - Douglas Pharmaceuticals RTD.

Title:

徐放性医薬製剤

Document Type and Number:

Japanese Patent JP2023543211

Kind Code:

A

Abstract:

本開示は、治療抵抗性のうつ病および治療抵抗性の不安の治療のための経口徐放性製剤を利用する投薬レジメンを提供する。【選択図】なし

Inventors:

Glue, Paul William
Medricot, Natalie June
Sirman, Peter William
Ron, Yuefeng

Application Number:

JP2023518735A

Publication Date:

October 13, 2023

Filing Date:

September 22, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Douglas Pharmaceuticals RTD.

International Classes:

A61K31/135; A61K9/22; A61K9/28; A61K47/10; A61K47/12; A61K47/14; A61K47/20; A61K47/34; A61K47/36; A61K47/38; A61K47/42; A61K47/44; A61K47/46; A61P25/22; A61P25/24

Attorney, Agent or Firm:

Tadashige Ito
Koichi Hirota
Tadahiko Ito

Previous Patent: Refrigerated cabinet kit that can be installed on-site, refrigerated vending machine, and how to use...

Next Patent: 3-[(1H-pyrazol-4-yl)oxy]pyrazin-2-amine compounds and their use as HPK1 inhibitors